[go: up one dir, main page]

MX2023006855A - DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLORINE KYNURENINE - Google Patents

DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLORINE KYNURENINE

Info

Publication number
MX2023006855A
MX2023006855A MX2023006855A MX2023006855A MX2023006855A MX 2023006855 A MX2023006855 A MX 2023006855A MX 2023006855 A MX2023006855 A MX 2023006855A MX 2023006855 A MX2023006855 A MX 2023006855A MX 2023006855 A MX2023006855 A MX 2023006855A
Authority
MX
Mexico
Prior art keywords
kynurenine
chlorine
dosage forms
therapeutic uses
therapeutic
Prior art date
Application number
MX2023006855A
Other languages
Spanish (es)
Inventor
H Ralph Snodgrass
Allen E Cato
Jack S Hicklin
Original Assignee
Vistagen Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vistagen Therapeutics Inc filed Critical Vistagen Therapeutics Inc
Priority to MX2023006855A priority Critical patent/MX2023006855A/en
Publication of MX2023006855A publication Critical patent/MX2023006855A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurological dysfunction.
MX2023006855A 2023-06-08 2023-06-08 DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLORINE KYNURENINE MX2023006855A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2023006855A MX2023006855A (en) 2023-06-08 2023-06-08 DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLORINE KYNURENINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2023006855A MX2023006855A (en) 2023-06-08 2023-06-08 DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLORINE KYNURENINE

Publications (1)

Publication Number Publication Date
MX2023006855A true MX2023006855A (en) 2025-01-09

Family

ID=95123275

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023006855A MX2023006855A (en) 2023-06-08 2023-06-08 DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLORINE KYNURENINE

Country Status (1)

Country Link
MX (1) MX2023006855A (en)

Similar Documents

Publication Publication Date Title
CO2020010956A2 (en) Compositions and methods for the treatment of cancer and immune disorders using veillonella bacteria
MX2019002750A (en) Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer.
MX2022009309A (en) COMPOUNDS AND USES THEREOF.
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
MX2020008680A (en) Combination therapy with apilimod and glutamatergic agents.
MX2018005315A (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER.
EA202092225A1 (en) CONNECTIONS AND THEIR APPLICATION
CL2021002878A1 (en) Treatment and prevention of metabolic diseases
EA202192122A1 (en) COMPOUNDS WITH FERROPTOSE-INDUCING ACTIVITY AND METHODS FOR THEIR APPLICATION
MX2023004920A (en) Bcl6 inhibitors.
CO2022007814A2 (en) Tyk2 pseudokinase ligands
MX2024006768A (en) COMPOUNDS AND THEIR USES.
EA202192905A1 (en) COMPOUNDS CONTAINING N-METHYL-2-PYRIDONE AND PHARMACEUTICALLY ACCEPTABLE SALTS
CL2019001749A1 (en) Use of anti-sclerostin antibodies in the treatment of imperfect osteogenesis.
MX2022008478A (en) Low-dose brimonidine combinations and uses thereof.
ECSP20077106A (en) DOSING REGIME FOR THE TREATMENT OF PI3K-RELATED DISORDERS
CL2021001656A1 (en) Imidazopyridine and imidazopyridine compounds and their uses.
BR112022009710A2 (en) COMBINATION THERAPY COMPRISING AN ALK2 INHIBITOR AND A JAK2 INHIBITOR
CL2020000508A1 (en) Anti-egfr drug-antibody (adc) conjugates and their uses.
MX2023010711A (en) Phenalkylamines and methods of making and using the same.
EA202192047A1 (en) COMPOUNDS AND THEIR APPLICATIONS
EA201792571A1 (en) THERAPEUTIC APPLICATION OF L-4-CHLOROKINURENIN
CL2023001637A1 (en) Jak1 pathway inhibitors for the treatment of vitiligo.
MX375318B (en) DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLORINE KYNURENINE.
EA201891439A1 (en) TRICYCLIC COMPOUNDS AND THEIR COMPOSITIONS AS A KINAZ INHIBITOR